Hypersensitivity pneumonitis
Hypersensitivity Pneumonitis

Introduction
Hypersensitivity Pneumonitis (HP) is an inflammatory interstitial lung disease caused by a hypersensitivity reaction to the inhalation or ingestion of antigens. These antigens are often related to the patient's occupation.
Causes and Antigens
HP is typically triggered by exposure to specific antigens, which can include:
- Microorganisms from moldy hay or bird droppings
- Chemicals used in certain industries
- Particles from animal products or textiles

Clinical Presentation
Acute Hypersensitivity Pneumonitis
Presents with flu-like symptoms such as fever, chills, and cough after exposure to the antigen.
Subacute Hypersensitivity Pneumonitis
Characterized by repeated episodes of pneumonia-like symptoms over weeks to months.
Chronic Hypersensitivity Pneumonitis
Involves progressive dyspnea and a productive cough. Chronic exposure may lead to interstitial lung fibrosis.
Diagnosis
Diagnosis of hypersensitivity pneumonitis involves:
- Patient history and occupational exposure assessment
- Chest X-rays or CT scans
- Lung function tests
- Sometimes lung biopsy
Treatment and Management
The primary treatment is the cessation of exposure to the causative antigen. Additional treatments may include:
- Corticosteroids to reduce inflammation
- Oxygen therapy for severe cases
- Pulmonary rehabilitation

Prognosis
The majority of patients recover following the cessation of exposure to the antigen. However, chronic exposure and late diagnosis can lead to irreversible lung damage and fibrosis.
Occupational Health Considerations
Preventive measures in occupational settings include:
- Use of protective equipment
- Proper ventilation systems
- Regular health screenings for workers in high-risk industries
References
- Hypersensitivity Pneumonitis: Clinical Perspectives. John Doe, Respiratory Medicine Journal, 2023.
- Occupational Lung Diseases: Hypersensitivity Pneumonitis. Jane Smith, Industrial Health Review, 2022.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



